290 related articles for article (PubMed ID: 4213329)
1. Pseudomonas aeruginosa infection in cystic fibrosis. Distribution of B and T lymphocytes in relation to the humoral immune response.
Hoiby N; Mathiesen L
Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Aug; 82(4):559-66. PubMed ID: 4213329
[No Abstract] [Full Text] [Related]
2. Pseudomonas aeruginosa infection in cystic fibrosis. Relationship between mucoid strains of Pseudomonas aeruginosa and the humoral immune response.
Hoiby N
Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Aug; 82(4):551-8. PubMed ID: 4213330
[No Abstract] [Full Text] [Related]
3. Pseudomonas aeruginosa infection in cystic fibrosis. Relative prevalence of antibodies in serum against cathodic and anodic migrating P. aeruginosa antigens determined by immunoelectrophoretic methods.
Holby N
Acta Pathol Microbiol Scand C; 1977 Apr; 85(2):149-52. PubMed ID: 67746
[TBL] [Abstract][Full Text] [Related]
4. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. A survey.
Hoiby N
Acta Pathol Microbiol Scand Suppl; 1977; (262):1-96. PubMed ID: 411327
[No Abstract] [Full Text] [Related]
5. Nitroblue-tetrazolium staining of human neutrophil granulocytes. Effects of stimulation with Pseudomonas antigens in the presence or absence of human Pseudomonas precipitins.
Koch C; Hoiby N
Acta Pathol Microbiol Scand B Microbiol Immunol; 1973 Dec; 81(6):787-94. PubMed ID: 4131384
[No Abstract] [Full Text] [Related]
6. Pseudomonas aeruginosa infection in cystic fibrosis. Occurrence of precipitating antibodies against pseudomonas aeruginosa in relation to the concentration of sixteen serum proteins and the clinical and radiographical status of the lungs.
Hoiby N; Jacobsen L; Jorgensen BA; Lykkegaard E; Weeke B
Acta Paediatr Scand; 1974 Nov; 63(6):843-8. PubMed ID: 4215280
[No Abstract] [Full Text] [Related]
7. Antibacterial precipitins and autoantibodies in serum of patients with cystic fibrosis.
Høiby N; Wiik A
Scand J Respir Dis; 1975 May; 56(1):38-46. PubMed ID: 238280
[TBL] [Abstract][Full Text] [Related]
8. Pseudomonas aeruginosa and Burkholderia cenocepacia infections in patients affected by cystic fibrosis: serum resistance and antibody response.
Savoia D; Deplano C; Zucca M
Immunol Invest; 2008; 37(1):19-27. PubMed ID: 18214797
[TBL] [Abstract][Full Text] [Related]
9. IgG subclasses and chronic bacterial infection. Subclass antibodies and the clinical course of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis.
Pressler T
APMIS Suppl; 1996; 66():1-41. PubMed ID: 8972694
[No Abstract] [Full Text] [Related]
10. Type III apparatus of Pseudomonas aeruginosa as a tool to diagnose pulmonary infection in cystic fibrosis patients.
Cruz AC; Neves BC; Higa LY; Folescu T; Marques EA; Milagres LG
APMIS; 2012 Aug; 120(8):622-7. PubMed ID: 22779684
[TBL] [Abstract][Full Text] [Related]
11. Interaction between Pseudomonas aeruginosa and host defenses in cystic fibrosis.
Marshall BC; Carroll KC
Semin Respir Infect; 1991 Mar; 6(1):11-8. PubMed ID: 1909452
[TBL] [Abstract][Full Text] [Related]
12. [Anti-pseudomonas-specific precipitins as a marker of chronic infection in patients with cystic fibrosis].
Castello D; Mari C; Visca A
Minerva Pediatr; 1999 Mar; 51(3):47-51. PubMed ID: 10368566
[TBL] [Abstract][Full Text] [Related]
13. [Anti-Pseudomonas aeruginosa antibodies, circulating immune complexes, and anticytoplasm antibodies of neutrophils in patients with cystic fibrosis with and without Pseudomonas aeruginosa colonization].
Chiappini E; Taccetti G; Campana S; Turchini S; Marianelli L
Pediatr Med Chir; 2001; 23(1):27-30. PubMed ID: 11486418
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptors in the host defense against Pseudomonas aeruginosa respiratory infection and cystic fibrosis.
McIsaac SM; Stadnyk AW; Lin TJ
J Leukoc Biol; 2012 Nov; 92(5):977-85. PubMed ID: 22892106
[TBL] [Abstract][Full Text] [Related]
15. Local humoral immunity and immune reactions in the lungs of patients with cystic fibrosis.
Schiøtz PO
Acta Pathol Microbiol Scand Suppl; 1981; 276():1-25. PubMed ID: 6951389
[No Abstract] [Full Text] [Related]
16. [Pseudomonas aeruginosa antibodies in patients with cystic fibrosis: clinical implications].
Marianelli L; Campana S; Taccetti G; Gabbrielli M; Dei R
Pediatr Med Chir; 1994; 16(6):551-4. PubMed ID: 7708538
[TBL] [Abstract][Full Text] [Related]
17. Antibody response to Pseudomonas aeruginosa in children with cystic fibrosis.
Milagres LG; Castro TL; Garcia D; Cruz AC; Higa L; Folescu T; Marques EA
Pediatr Pulmonol; 2009 Apr; 44(4):392-401. PubMed ID: 19283764
[TBL] [Abstract][Full Text] [Related]
18. Vaccine strategies against Pseudomonas aeruginosa infection in the lung.
Cripps AW; Dunkley ML; Clancy RL; Kyd J
Behring Inst Mitt; 1997 Feb; (98):262-8. PubMed ID: 9382749
[TBL] [Abstract][Full Text] [Related]
19. Identification and quantitation of precipitins against Pseudomonas aeruginosa in patients with cystic fibrosis by means of crossed immunoelectrophoresis with intermediate gel.
Hoiby N; Axelsen NH
Acta Pathol Microbiol Scand B Microbiol Immunol; 1973 Jun; 81(3):298-308. PubMed ID: 4204843
[No Abstract] [Full Text] [Related]
20. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
Ciofu O
APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
